Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Wellbutrin Sr

Wellbutrin Sr
In stock
150mg
from A$84.60
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$101.52A$84.60
A$2.82 per tablet

In brief

  • In our pharmacy, you can buy wellbutrin sr without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
  • Wellbutrin SR (bupropion hydrochloride) is an aminoketone antidepressant used mainly for major depressive disorder and also used off‑label for smoking cessation and some other conditions; it acts as a norepinephrine–dopamine reuptake inhibitor (NDRI) and has nicotinic receptor antagonist activity that helps reduce cravings.
  • The usual dose for the sustained‑release formulation is 150 mg twice daily (often started as 150 mg once daily for 3 days then 150 mg twice daily), with a common total daily dose of up to 300 mg depending on response and tolerability.
  • The form of administration is oral sustained‑release tablets, taken by mouth with or without food.
  • Initial antidepressant effects can be noticed within 1–2 weeks in some people, with more substantial clinical benefit often seen by 4–6 weeks.
  • The SR formulation provides about 12 hours of therapeutic coverage per dose (bupropion has an effective half‑life around 21 hours, with clinical dosing schedules designed to maintain levels across the day).
  • Avoid alcohol where possible; combining alcohol with bupropion increases the risk of adverse effects and seizures, and abrupt alcohol withdrawal also raises seizure risk.
  • The most common side effects include insomnia, dry mouth, headache, nausea and tremor; less commonly, it can increase the risk of seizures, especially at higher doses or with certain risk factors.
  • Would you like to try wellbutrin sr without a prescription?

Critical Safety, Warnings & Patient Protection (Australia)

Basic Wellbutrin Sr Information

  • INN (International Nonproprietary Name): Bupropion
  • Brand Names Available In Australia: Zyban SR (for smoking cessation), generic Bupropion SR; Wellbutrin not commonly branded locally
  • ATC Code: not specified
  • Forms & Dosages: Sustained‑release tablets 150 mg
  • Manufacturers In Australia: not specified
  • Registration Status In Australia: Zyban SR and generic Bupropion SR are listed in product overviews for Australia
  • OTC / Rx Classification: not specified

Summary Of Top Risks And How To Protect Patients

Starting a sustained‑release bupropion product raises a few key safety priorities patients must know about.

Seizure risk is dose‑related and is the principal safety concern; avoid doses above recommended limits and screen for risk factors.

Young adults starting antidepressants can have an increased risk of emergence of suicidal thoughts; set up a monitoring plan.

Interactions that raise bupropion levels or lower seizure threshold require reconciliation of prescription, OTC and herbal medicines.

Abrupt withdrawal can produce symptoms; counsel patients on safe stopping and follow‑up.

Pregnancy and breastfeeding decisions need a risk–benefit discussion with the patient’s obstetrician and treating GP.

Misuse is uncommon but possible; limit supply and record clear indications when concerned.

  • Clinical actions: baseline seizure‑risk screen and alcohol/substance‑use check.
  • Clinical actions: complete medication reconciliation and agree a mental‑state monitoring plan with crisis contacts.

Micro‑FAQ

Q: “Can I Drive After Taking It In Australia?”

Most people can drive while taking bupropion SR, but monitor for dizziness, sedation, blurred vision or sudden mood changes.

If any of these occur, do not drive and contact the GP or pharmacist before resuming driving.

If the patient’s job is safety‑critical, advise they report this to their employer and seek medical advice.

High‑Risk Groups

Specific Patient Groups And Tailored Precautions

Elderly patients need careful review of cardiac history, renal and hepatic function and total medication load to reduce falls and interactions.

Start low and titrate slowly in older adults while monitoring blood pressure and any balance or cognitive changes.

Pregnancy and breastfeeding data are limited for bupropion SR; decisions should follow a discussion with the obstetrician and GP about risks and benefits.

Epilepsy or structural brain lesions increase seizure risk; bupropion is contraindicated in patients with uncontrolled seizures and in bulimia or anorexia nervosa due to electrolyte and withdrawal risks.

Hepatic impairment may require dose caution and closer monitoring, and severe renal disease should prompt periodic review.

Coexisting bipolar disorder should be stabilised; use mood stabiliser cover to reduce the risk of mood switching to mania.

  • Contraindications: uncontrolled seizures, eating disorders with high seizure risk, known hypersensitivity to bupropion.
  • Monitoring frequency: mental‑state checks at weeks 1, 2 and 4, then monthly as needed; LFTs if clinically indicated.

Patient protection tools: provide a written action plan, pharmacist counselling card and encourage early contact with GP or emergency services for severe adverse events.

Legal Status, Approvals & Australian Context

TGA, PBS, Scheduling And Branding

Bupropion SR is sold internationally in SR and XL/ER forms, and in Australia Zyban SR and generic bupropion SR are the familiar names.

Wellbutrin is not commonly used as a brand name locally, so confirm the exact product on the prescription and at dispensing.

Prescribers and pharmacists should confirm current TGA registration and PBS listing at the time of prescribing to know subsidy status.

Scheduling in Australia is prescription‑only (S4) in routine practice; pharmacists must verify valid prescriptions and follow dispensing rules.

Rural patients commonly use community pharmacy or telehealth to access bupropion SR, but remote reviews can make a full polypharmacy check harder.

Stakeholder Role
TGA Regulatory approval and product information oversight
PBS Subsidy and listing rules—check current criteria
Chemist Warehouse Major retail chain; often stocks generics and branded products
Priceline Major retail chain; community access and patient pickup
TerryWhite Chemmart Major community pharmacy network with pharmacist counselling services
  • Prescriber/pharmacist checklist: confirm PBS criteria, TGA registration and exact brand/formulation before issuing or dispensing.

Dosing Guide & Practical Titration (SR Specifics)

Typical Regimens, Starting Doses And Maximums

Sustained‑release bupropion commonly comes as 150 mg SR tablets in Australia and is used for depression or smoking cessation.

A typical regimen starts with 150 mg once daily for a few days, then increases to 150 mg twice daily as tolerated for both MDD and smoking cessation protocols.

Extended‑release (XL) formulations differ and are taken once daily; be careful not to confuse SR dosing schedules with XL schedules.

The maximum daily dose should stay within recommended limits for the chosen formulation to reduce seizure risk and other adverse effects.

  • Stepwise titration: 150 mg once daily for 3 days → 150 mg twice daily if tolerated; review within 1–2 weeks.
  • Monitoring checklist: sleep changes, anxiety, blood pressure, mood swings and any neurologic symptoms.

Micro‑FAQ

Q: “What If I Miss A Dose?”

If a single dose is missed, take it as soon as remembered on the same day and return to the usual schedule.

Do not double the next dose to catch up and contact the GP if multiple doses are missed or withdrawal symptoms occur.

If close to the next scheduled dose, skip the missed dose and resume the normal dosing times.

Drug–Drug, Food & Substance Interactions

High‑Priority Interactions And Everyday Substances

Avoid combining bupropion with monoamine oxidase inhibitors (MAOIs) because of potentially dangerous hypertensive or serotonergic effects.

Other agents that lower seizure threshold—such as some antipsychotics, tramadol and stimulants—require caution and review before co‑prescription.

Drugs that inhibit or induce CYP2B6 may alter bupropion plasma concentrations and therefore its effect and side‑effect profile.

Alcohol raises seizure risk, especially during withdrawal, and can worsen depressive symptoms; counsel moderation and seek help for dependence.

Caffeine or other stimulants may worsen anxiety and insomnia when starting bupropion SR and should be reviewed with the patient.

Interacting Agent Risk Action
MAOIs Hypertensive or serotonergic reactions Avoid; observe washout periods
Tramadol, Some Antipsychotics Increased seizure risk Use alternative analgesics or review therapy
CYP2B6 Inhibitors/Inducers Altered bupropion levels Adjust dose or monitor clinically
  • Tell the pharmacist about all medicines, including supplements and herbal products, before starting bupropion SR.
  • Declare alcohol use and recent withdrawal history at every supply.

Mechanism Of Action & Pharmacology (Plain & Clinical)

How Bupropion Works And Clinical Implications

Bupropion is an aminoketone antidepressant that primarily inhibits the reuptake of dopamine and noradrenaline, which can lift mood and reduce nicotine cravings.

It has negligible direct serotonergic activity, which often means lower rates of sexual dysfunction compared with SSRIs.

The drug is metabolised mainly via CYP2B6 to active metabolites, and SR formulations release drug over several hours to blunt peak concentrations and some side effects.

XL or ER products differ in once‑daily kinetics and are not interchangeable on a milligram‑for‑milligram basis without prescriber review.

  • Definitions: INN = Bupropion; class = aminoketone antidepressant; main actions = dopamine and noradrenaline reuptake inhibition.
  • Clinical implications: onset of effect usually several weeks; seizure risk is dose‑related and linked to peak plasma concentrations and patient risk factors.

Indications: TGA‑Labelled And Common Off‑Label Uses

Approved Uses And Real‑World Practice

Bupropion SR is used for major depressive disorder and Zyban SR is the widely recognised preparation for smoking cessation in many countries including Australia.

Always check the TGA product information and individual brand labelling for the exact registered indications before prescribing or dispensing.

Off‑label uses seen in practice include adjunctive treatment in resistant depression, adult ADHD and managing SSRI‑related sexual dysfunction under specialist oversight.

Use Labelled Or Off‑Label
Major Depressive Disorder Labelled
Smoking Cessation (Zyban SR) Labelled
Adjunctive Treatment In Resistant Depression Off‑Label
  • When using off‑label, document rationale, discuss risks with the patient and obtain informed consent.

Efficacy & Key Clinical Findings (Recent Evidence)

Summary Of The Evidence Base Relevant To Australia

Randomised trials and meta‑analyses show bupropion is effective for major depressive disorder and for smoking cessation compared with placebo.

Clinical advantages include lower rates of sexual side effects and potential benefits for energy and concentration compared with some alternatives.

Important risks remain dose‑dependent seizures and rare reports of hepatotoxicity; these are emphasised in safety counselling.

In practice, symptomatic improvement is generally expected over several weeks, and smoking‑cessation regimens usually begin dose escalation before the patient’s quit date.

  • Main outcomes: efficacy for mood and for smoking cessation, time to effect several weeks, side effects include insomnia and dry mouth.
  • Readers should consult up‑to‑date clinical guidelines and recent RCTs or systematic reviews when planning therapy.

Common Adverse Effects, Warning Signs & Monitoring

Side Effects Frequency And What To Watch For

Common adverse effects include insomnia, dry mouth, headache, tremor, sweating, anxiety and decreased appetite with possible weight loss.

Less common but serious events include seizures, severe allergic reactions, hypertensive episodes, mood switching to mania and increased suicidal thoughts in younger adults.

Baseline checks should include vital signs and a documented seizure‑risk review with follow‑up mental‑state monitoring at weeks 1, 2 and 4.

Consider liver function testing if clinical signs suggest hepatic involvement or if interacting hepatotoxic drugs are in use.

  • Routine monitoring checklist: BP and heart rate baseline, mental‑state review schedule, medication reconciliation at each visit.
  • Urgent red flags: new or worsening suicidal thoughts, new seizures, severe rash or signs of hypersensitivity—seek emergency care.

Pharmacy safety tool: provide a patient safety card listing indication, dose, emergency contacts and red flags to watch for.

Alternatives And When To Switch

PBS‑Listed Alternatives, Pros/Cons, And Switching Checklist

Common PBS‑listed alternatives include SSRIs such as sertraline and escitalopram, SNRIs like venlafaxine and duloxetine, and other antidepressants such as mirtazapine.

Bupropion XL is an alternative when once‑daily dosing is preferred, while choice depends on side‑effect profile, seizure risk and coexisting conditions.

Consider switching when there is inadequate response after an adequate trial, intolerable adverse effects, pregnancy planning or problematic interactions.

Drug Typical Starting Dose Common Side Effects PBS Status
Sertraline 50 mg daily Nausea, sexual dysfunction PBS listed
Venlafaxine 75 mg daily Insomnia, BP rise PBS listed
Bupropion XL 150–300 mg once daily Insomnia, dry mouth Check listing
  • Switch checklist: review washout or cross‑taper timing, plan monitoring, update patient information and confirm follow‑up.

Access, Prescriptions & Where To Buy In Australia

Community, Online And Telehealth Options

Patients typically get bupropion SR via GP prescriptions, psychiatrists or telehealth e‑prescriptions which community pharmacies will dispense.

Major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart and accredited online pharmacies commonly supply bupropion SR.

In our online pharmacy, wellbutrin sr is available without a prescription, with discreet delivery to Australia in 9-21 days.

Always verify prescriber credentials, prescription validity and pharmacy accreditation when ordering online to ensure safe supply.

Pharmacy Channel Availability Pros / Cons
Chain Retailers High Price competitive, wide stock, possible longer wait for counselling
Independent Pharmacies Moderate Personal counselling, variable stock and pricing
Accredited Online Pharmacy Moderate Convenience, discrete delivery; verify accreditation and prescriber
  • Safe online purchase checklist: confirm prescriber registration, pharmacy accreditation and valid e‑prescription before payment.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Geelong Victoria 9-14 days
Cairns Queensland 14-21 days
Townsville Queensland 14-21 days
Launceston Tasmania 14-21 days

Price, PBS Subsidy & Cost‑Saving Tips

How To Check Subsidy Status And Minimise Out‑Of‑Pocket Costs

Price varies by brand, pack size and pharmacy, and PBS subsidy status can change, so check the PBS website or ask the local pharmacist at prescribing time.

Generic bupropion SR is usually less expensive than branded Zyban SR 150mg, and substitution can save money when clinically appropriate.

Patients eligible for concession cards should bring them to the pharmacy and ask about repeat dispensing options to reduce dispensing fees.

Pharmacy Brand / Generic PBS Status Typical Out‑Of‑Pocket
Chemist Warehouse Generic Bupropion SR Varies Lower range
Priceline Zyban SR / Generic Varies Mid range
Independent Pharmacy Generic / Branded Varies Variable
  • Cost‑saving checklist: ask about generic substitution, check concession card eligibility, and request repeat prescriptions where safe.

Storage, Handling & Disposal (Australian Climate)

Home And Pharmacy‑Level Guidance

Store SR tablets in the original container at room temperature away from heat and humidity and avoid exposure above about 25–30°C.

In hot or humid parts of Australia, recommend storage in a cool, shaded place or air‑conditioning when available; do not leave medicine in a hot car or glove box.

Pharmacies should use standard ambient storage and check expiry dates and the physical integrity of sustained‑release tablets at dispense.

Advise patients not to crush or split SR tablets unless the product information explicitly permits it because this can destroy the sustained‑release mechanism.

Dispose of unwanted or expired medicines via the community pharmacy Return Unwanted Medicines (RUM) program and do not flush medicines down the toilet.

  • Household checklist: original container, cool shaded storage, keep out of reach of children, return unused medicine to pharmacy.
  • Pharmacy SOPs: check packaging integrity, expiry, and counsel on storage and disposal at supply.

Counselling Scripts & Pharmacist Checklist

Practical Counselling Points To Cover In 5–10 Minutes

Explain the purpose of treatment clearly—whether for major depressive disorder or for smoking cessation—and expected onset of effects over several weeks.

Discuss the dosing schedule, emphasise taking the SR 150 mg tablets as prescribed and avoiding late evening dosing to reduce insomnia.

Cover common side effects and simple management tips such as good sleep hygiene for insomnia and staying hydrated for dry mouth.

Highlight red flags—suicidality, new seizures or severe allergic reactions—and provide crisis contact numbers and a follow‑up plan with the GP.

Use teach‑back to check understanding, provide a written short‑form leaflet and agree a GP follow‑up within 1–2 weeks of starting therapy.

  • Pharmacist checklist (S2P): Suitability, Safety, Plan—confirm indication, screen for risks, advise monitoring and arrange follow‑up.

Stopping, Switching And Long‑Term Follow Up

Safe Cessation, Tapering Principles And Monitoring Long‑Term Outcomes

Abrupt stopping of regular antidepressant therapy is best avoided; taper over days to weeks depending on dose, formulation and clinical context.

Monitor for discontinuation symptoms such as irritability, sleep disturbance or mood relapse and arrange early review if these occur.

When switching antidepressants, plan a cross‑taper or washout guided by the interacting agent and local clinical guidelines to reduce serotonin or seizure‑related risks.

Switching from SR to XL/ER requires prescriber review to match daily exposure and adjust timing appropriately.

Long‑term follow up should include periodic mental‑health reviews, suicide‑risk checks, and monitoring for adverse effects and comorbidity‑related concerns.

  • Stepwise taper checklist: review indication, reduce dose gradually, schedule follow‑up within 1–2 weeks of dose change, and provide relapse plan.
  • Recommended follow‑up intervals: 1–2 weeks after initiation, then 4 weeks, then monthly or as clinically indicated.

Related products